Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FQPJA
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,777
Award facts
- Contract value 100% obligated
- $2,777.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $2,777.24 by the Defense Logistics Agency on June 17, 2025, for the supply of Nexplanon 68 mg implants. The contract, which carries an ultimate completion date of July 10, 2025, represents a discrete delivery order issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at approximately $500 million through November 2026. No set-aside designation was applied to this delivery order, allowing the company to compete on its merits in the federal procurement marketplace.
This award reflects DMS Pharmaceutical Group's established role as a critical supplier in the federal pharmaceutical supply chain, supporting the Department of Defense healthcare system with a comprehensive range of medical products including prescription medications, biologics, and specialty pharmaceuticals. The Nexplanon implant delivery supports military health facility requirements for contraceptive devices and demonstrates the vendor's capability to supply specialized pharmaceutical products to military healthcare sites nationwide. The company's consistent contract performance and broad product portfolio have positioned it as a preferred vendor for the Defense Logistics Agency's pharmaceutical distribution needs.
Quick answers
Who was awarded contract SPE2DB25FQPJA?
SPE2DB25FQPJA was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 17, 2025.
How much is contract SPE2DB25FQPJA worth?
The government has obligated $2,777 on SPE2DB25FQPJA.
Is contract SPE2DB25FQPJA an order under another contract?
Yes. SPE2DB25FQPJA is a delivery order under SPE2DB25D9240, an indefinite delivery contract.
Was contract SPE2DB25FQPJA competed?
The extent of competition for SPE2DB25FQPJA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award